Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-844
Closed -$19K 567
2019
Q3
$19K Hold
844
﹤0.01% 569
2019
Q2
$20K Hold
844
﹤0.01% 676
2019
Q1
$11K Buy
844
+115
+16% +$2.01K ﹤0.01% 690
2018
Q4
$11K Buy
729
+328
+82% +$8.48K ﹤0.01% 783
2018
Q3
$16K Hold
401
﹤0.01% 819
2018
Q2
$20K Buy
401
+86
+27% +$4.88K ﹤0.01% 743
2018
Q1
$19K Buy
315
+20
+7% +$1.33K ﹤0.01% 781
2017
Q4
$23K Hold
295
﹤0.01% 878
2017
Q3
$25K Buy
295
+19
+7% +$1.35K ﹤0.01% 879
2017
Q2
$18K Hold
276
﹤0.01% 869
2017
Q1
$20K Hold
276
﹤0.01% 772
2016
Q4
$16K Buy
+276
New +$14.6K ﹤0.01% 797

Other funds holding ADNT

First Quadrant's ADNT Position: Q4 2019 in Review

First Quadrant sold out of Adient (ADNT) in Q4 2019, closing a stake of 844 shares — an estimated $19K sold.

First Quadrant first reported a position in ADNT in Q4 2016 and held it in 12 quarters. The position peaked at $25K in Q3 2017. 315 funds tracked by Wall St. Rank hold ADNT as of Q4 2019.

  • First Quadrant reported no remaining Adient position as of Q4 2019 after selling out during the quarter.
  • First Quadrant sold 844 Adient shares in Q4 2019, an estimated $19K.
  • First Quadrant first reported a position in Adient in Q4 2016 and held it in 12 quarters.
  • First Quadrant's Adient position peaked at $25K in Q3 2017.
  • 315 funds tracked by Wall St. Rank held Adient as of Q4 2019.

Based on First Quadrant's 13F filing for Q4 2019, filed 28 Jan 2020.